Bondrescu, M.; Dehelean, L.; Farcas, S.S.; Papava, I.; Nicoras, V.; Mager, D.V.; Grecescu, A.E.; Podaru, P.A.; Andreescu, N.I.
COMT and Neuregulin 1 Markers for Personalized Treatment of Schizophrenia Spectrum Disorders Treated with Risperidone Monotherapy. Biomolecules 2024, 14, 777.
https://doi.org/10.3390/biom14070777
AMA Style
Bondrescu M, Dehelean L, Farcas SS, Papava I, Nicoras V, Mager DV, Grecescu AE, Podaru PA, Andreescu NI.
COMT and Neuregulin 1 Markers for Personalized Treatment of Schizophrenia Spectrum Disorders Treated with Risperidone Monotherapy. Biomolecules. 2024; 14(7):777.
https://doi.org/10.3390/biom14070777
Chicago/Turabian Style
Bondrescu, Mariana, Liana Dehelean, Simona Sorina Farcas, Ion Papava, Vlad Nicoras, Dana Violeta Mager, Anca Eliza Grecescu, Petre Adrian Podaru, and Nicoleta Ioana Andreescu.
2024. "COMT and Neuregulin 1 Markers for Personalized Treatment of Schizophrenia Spectrum Disorders Treated with Risperidone Monotherapy" Biomolecules 14, no. 7: 777.
https://doi.org/10.3390/biom14070777
APA Style
Bondrescu, M., Dehelean, L., Farcas, S. S., Papava, I., Nicoras, V., Mager, D. V., Grecescu, A. E., Podaru, P. A., & Andreescu, N. I.
(2024). COMT and Neuregulin 1 Markers for Personalized Treatment of Schizophrenia Spectrum Disorders Treated with Risperidone Monotherapy. Biomolecules, 14(7), 777.
https://doi.org/10.3390/biom14070777